(State or Other Jurisdiction of Incorporation or Organization) | (IRS Employer Identification No.) |
(Address of Principal Executive Offices, Including Zip Code) | |
(Registrant's Telephone Number, Including Area Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Page |
(in thousands) | March 31, 2025 | December 31, 2024 | |
Assets | |||
Cash and cash equivalents | $ | $ | |
Restricted cash | |||
Loans, net (including $ | |||
Loans, held for sale (including $ allowance of $ | |||
Mortgage-backed securities | |||
Investment in unconsolidated joint ventures (including $ | |||
Derivative instruments | |||
Servicing rights | |||
Real estate owned, held for sale | |||
Other assets | |||
Assets of consolidated VIEs | |||
Assets held for sale (refer to Note 9) | |||
Total Assets | $ | $ | |
Liabilities | |||
Secured borrowings | |||
Securitized debt obligations of consolidated VIEs, net | |||
Senior secured notes, net | |||
Corporate debt, net | |||
Guaranteed loan financing | |||
Contingent consideration | |||
Derivative instruments | |||
Dividends payable | |||
Loan participations sold | |||
Due to third parties | |||
Accounts payable and other accrued liabilities | |||
Liabilities held for sale (refer to Note 9) | |||
Total Liabilities | $ | $ | |
Preferred stock Series C, liquidation preference $ | |||
Commitments & contingencies (refer to Note 24) | |||
Stockholders’ Equity | |||
Preferred stock Series E, liquidation preference $ | |||
Common stock, $ shares issued and outstanding, respectively | |||
Additional paid-in capital | |||
Retained earnings (deficit) | ( | ( | |
Accumulated other comprehensive loss | ( | ( | |
Total Ready Capital Corporation equity | |||
Non-controlling interests | |||
Total Stockholders’ Equity | $ | $ | |
Total Liabilities, Redeemable Preferred Stock, and Stockholders’ Equity | $ | $ |
Three Months Ended March 31, | |||
(in thousands, except share data) | 2025 | 2024 | |
Interest income | $ | $ | |
Interest expense | ( | ( | |
Net interest income before recovery of loan losses | $ | $ | |
Recovery of loan losses | |||
Net interest income after recovery of loan losses | $ | $ | |
Non-interest income | |||
Net realized gain (loss) on financial instruments and real estate owned | |||
Net unrealized gain (loss) on financial instruments | ( | ||
Valuation allowance, loans held for sale | ( | ( | |
Servicing income, net of amortization and impairment of $ | |||
Gain on bargain purchase | |||
Income (loss) on unconsolidated joint ventures | ( | ||
Other income | |||
Total non-interest income (expense) | $ | $( | |
Non-interest expense | |||
Employee compensation and benefits | ( | ( | |
Allocated employee compensation and benefits from related party | ( | ( | |
Professional fees | ( | ( | |
Management fees – related party | ( | ( | |
Loan servicing expense | ( | ( | |
Transaction related expenses | ( | ( | |
Impairment on real estate | ( | ( | |
Other operating expenses | ( | ( | |
Total non-interest expense | $( | $( | |
Income (loss) from continuing operations before benefit (provision) for income taxes | ( | ||
Income tax benefit | |||
Net income (loss) from continuing operations | $ | $( | |
Discontinued operations (refer to Note 9) | |||
Income (loss) from discontinued operations before benefit (provision) for income taxes | ( | ||
Income tax benefit (provision) | ( | ||
Net income (loss) from discontinued operations | $( | $ | |
Net income (loss) | $ | $( | |
Less: Dividends on preferred stock | |||
Less: Net income attributable to non-controlling interest | |||
Net income (loss) attributable to Ready Capital Corporation | $ | $( | |
Earnings per common share from continuing operations - basic | $ | $( | |
Earnings per common share from discontinued operations - basic | $ | $ | |
Total earnings per common share - basic | $ | $( | |
Earnings per common share from continuing operations - diluted | $ | $( | |
Earnings per common share from discontinued operations - diluted | $ | $ | |
Total earnings per common share - diluted | $ | $( | |
Weighted-average shares outstanding | |||
Basic | |||
Diluted | |||
Dividends declared per share of common stock | $ | $ |
Three Months Ended March 31, | |||
(in thousands) | 2025 | 2024 | |
Net income (loss) | $ | $( | |
Other comprehensive income (loss) - net change by component: | |||
Derivative financial instruments (cash flow hedges) | ( | ||
Foreign currency translation | ( | ||
Other comprehensive income (loss) | $( | $ | |
Comprehensive income (loss) | $ | $( | |
Less: Comprehensive income attributable to non-controlling interests | |||
Comprehensive income (loss) attributable to Ready Capital Corporation | $ | $( |
Three Months Ended March 31, 2025 | |||||||||||||||||||
Preferred Series E | Common Stock | Additional Paid- In Capital | Retained Earnings (Deficit) | Accumulated Other Comprehensive Loss | Total Ready Capital Corporation Equity | Non-controlling Interests | Total Stockholders' Equity | ||||||||||||
(in thousands, except share data) | Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2024 | $ | $ | $ | $( | $( | $ | $ | $ | |||||||||||
Dividend declared: | |||||||||||||||||||
Common stock ($ | — | — | — | — | — | ( | — | ( | — | ( | |||||||||
OP units | — | — | — | — | — | — | — | — | ( | ( | |||||||||
$ | — | — | — | — | — | ( | — | ( | — | ( | |||||||||
$ | — | — | — | — | — | ( | — | ( | — | ( | |||||||||
Distributions, net | — | — | — | — | — | — | — | — | ( | ( | |||||||||
Shares issued pursuant to merger transaction | — | — | — | — | — | — | |||||||||||||
Stock-based compensation | — | — | — | — | — | — | |||||||||||||
Share repurchases | — | — | ( | — | ( | — | — | ( | — | ( | |||||||||
Reallocation of non-controlling interest | — | — | — | — | — | ( | ( | ||||||||||||
Net income | — | — | — | — | — | — | |||||||||||||
Other comprehensive loss | — | — | — | — | — | — | ( | ( | ( | ( | |||||||||
Balance at March 31, 2025 | $ | $ | $ | $( | $( | $ | $ | $ |
Three Months Ended March 31, 2024 | |||||||||||||||||||
Preferred Series E | Common Stock | Additional Paid- In Capital | Retained Earnings (Deficit) | Accumulated Other Comprehensive Loss | Total Ready Capital Corporation Equity | Non-controlling Interests | Total Stockholders' Equity | ||||||||||||
(in thousands, except share data) | Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2023 | $ | $ | $ | $ | $( | $ | $ | $ | |||||||||||
Dividend declared: | |||||||||||||||||||
Common stock ($ | — | — | — | — | — | ( | — | ( | — | ( | |||||||||
OP units | — | — | — | — | — | — | — | — | ( | ( | |||||||||
$ | — | — | — | — | — | ( | — | ( | — | ( | |||||||||
$ | — | — | — | — | — | ( | — | ( | — | ( | |||||||||
Distributions, net | — | — | ( | — | ( | — | — | ( | ( | ||||||||||
Stock-based compensation | — | — | — | — | — | — | |||||||||||||
Conversion of OP units into common stock | — | — | — | — | — | ( | |||||||||||||
Share repurchases | — | — | ( | — | ( | — | — | ( | — | ( | |||||||||
Reallocation of non-controlling interest | — | — | — | — | — | ( | ( | ||||||||||||
Net income (loss) | — | — | — | — | — | ( | — | ( | ( | ||||||||||
Other comprehensive income | — | — | — | — | — | — | |||||||||||||
Balance at March 31, 2024 | $ | $ | $ | $( | $( | $ | $ | $ |
Three Months Ended March 31, | |||
(in thousands) | 2025 | 2024 | |
Cash Flows From Operating Activities: | |||
Net income (loss) | $ | $( | |
Net income (loss) from discontinued operations, net of tax | ( | ||
Net income (loss) from continuing operations | ( | ||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||
Amortization of premiums, discounts, and debt issuance costs, net | |||
Stock-based compensation | |||
Recovery of loan losses | ( | ( | |
Impairment loss on real estate owned, held for sale | |||
Repair and denial reserve | |||
Paid-in-kind accrued interest | ( | ( | |
Provision for loan losses on purchased future receivables | |||
Valuation allowance, loans held for sale | |||
Net (income) loss of unconsolidated joint ventures, net of distributions | ( | ||
Realized (gains) losses, net | ( | ( | |
Unrealized (gains) losses, net | ( | ||
Bargain purchase gain | ( | ||
Loans, held for sale, net | |||
Changes in operating assets and liabilities: | |||
Derivative instruments | ( | ( | |
Assets of consolidated VIEs (excluding loans, net), accrued interest and due from servicers | ( | ||
Receivable from third parties | ( | ||
Other assets | ( | ( | |
Accounts payable and other accrued liabilities | ( | ||
Net cash provided by operating activities from continuing operations | $ | $ | |
Net cash provided by operating activities from discontinued operations | |||
Net cash provided by operating activities | $ | $ | |
Cash Flows From Investing Activities: | |||
Origination of loans | ( | ( | |
Proceeds from disposition and principal payment of loans | |||
Funding of real estate, held for sale | ( | ( | |
Proceeds from sale of real estate, held for sale | |||
Investment in unconsolidated joint ventures | ( | ( | |
Distributions in excess of cumulative earnings from unconsolidated joint ventures | |||
Proceeds from liabilities under participation agreements | |||
Payment of liabilities under participation agreements | ( | ||
Net cash provided by business acquisitions | |||
Net cash provided by investing activities from continuing operations | $ | $ | |
Net cash provided by (used for) investing activities from discontinued operations | ( | ||
Net cash provided by investing activities | $ | $ | |
Cash Flows From Financing Activities: | |||
Proceeds from secured borrowings | |||
Repayment of secured borrowings | ( | ( | |
Repayment of the Paycheck Protection Program Liquidity Facility borrowings | ( | ( | |
Repayment of securitized debt obligations of consolidated VIEs | ( | ( | |
Proceeds from senior secured note | |||
Repayment of corporate debt | ( | ||
Repayment of guaranteed loan financing | ( | ( | |
Payment of deferred financing costs | ( | ( | |
Common stock repurchased | ( | ( | |
Settlement of share-based awards in satisfaction of withholding tax requirements | ( | ( | |
Dividend payments | ( | ( | |
Distributions, net | ( | ||
Net cash used for financing activities from continuing operations | $( | $( | |
Net cash used for financing activities from discontinued operations | ( | ( | |
Net cash used for financing activities | $( | $( | |
Net increase (decrease) in cash, cash equivalents, and restricted cash including cash classified within assets held for sale | ( | ||
Less: Net decrease in cash and cash equivalents within assets held for sale | ( | ( | |
Net increase (decrease) in cash, cash equivalents, and restricted cash | ( | ||
Cash, cash equivalents, and restricted cash beginning balance | |||
Cash, cash equivalents, and restricted cash ending balance | $ | $ |
Three Months Ended March 31, | |||
(in thousands) | 2025 | 2024 | |
Supplemental disclosures: | |||
Cash paid for interest | $ | $ | |
Cash paid (received) for income taxes | $( | $ | |
Non-cash investing activities | |||
Loans transferred from loans, held for sale to loans, net | $ | $ | |
Loans transferred from loans, net to loans, held for sale | $ | $ | |
Loans transferred to real estate owned, held for sale | $ | $ | |
Contingent consideration in connection with acquisitions | $ | $ | |
Non-cash financing activities | |||
Shares and OP units issued in connection with merger transactions | $ | $ | |
Conversion of OP units to common stock | $ | $ | |
Cash, cash equivalents, and restricted cash reconciliation | |||
Cash and cash equivalents | $ | $ | |
Restricted cash | |||
Cash, cash equivalents, and restricted cash in assets of consolidated VIEs | |||
Cash, cash equivalents, and restricted cash ending balance | $ | $ |
(in thousands) | Preliminary Purchase Price Allocation |
Assets | |
Cash and cash equivalents | $ |
Loans, net | |
Investment in unconsolidated joint ventures | |
Other Assets: | |
Accrued interest | |
Receivable from third party | |
Other | |
Total assets acquired | $ |
Liabilities | |
Accounts payable and other accrued liabilities | |
Total liabilities assumed | $ |
Net assets acquired | $ |
(in thousands) | Preliminary Purchase Price Allocation |
Fair value of net assets acquired | $ |
Consideration transferred based on the value of common stock issued | |
Contingent consideration | |
Total consideration transferred | $ |
Bargain purchase gain | $ |
(in thousands) | Preliminary Purchase Price Allocation | Measurement Period Adjustments | Updated Purchase Price Allocation | ||
Assets | |||||
Cash and cash equivalents | $ | $— | $ | ||
Loans, net | — | ||||
Investment in unconsolidated joint ventures | — | ||||
Servicing rights | — | ||||
Other assets: | |||||
Deferred tax asset | — | ||||
Intangible assets | — | ||||
Other | — | ||||
Total assets acquired | $ | $ | $ | ||
Liabilities | |||||
Secured borrowings | — | ||||
Accounts payable and other accrued liabilities | — | ||||
Total liabilities assumed | $ | $ | $ | ||
Net assets acquired | $ | $ | $ |
(in thousands) | Preliminary Purchase Price Allocation | Measurement Period Adjustments | Updated Purchase Price Allocation | ||
Fair value of net assets acquired | $ | $— | $ | ||
Consideration transferred | — | ||||
Bargain purchase gain | $ | $ | $ |
(in thousands) | Preliminary Purchase Price Allocation | Measurement Period Adjustments | Updated Purchase Price Allocation | ||
Assets | |||||
Cash and cash equivalents | $ | $— | $ | ||
Restricted cash | ( | ||||
Servicing rights | |||||
Other assets: | |||||
Intangible assets | |||||
Other | — | ||||
Total assets acquired | $ | $ | $ | ||
Liabilities | |||||
Accounts payable and other accrued liabilities | |||||
Total liabilities assumed | $ | $ | $ | ||
Non-controlling interests | ( | — | ( | ||
Net assets acquired, net of non-controlling interests | $ | $( | $ |
(in thousands) | Preliminary Purchase Price Allocation | Measurement Period Adjustments | Updated Purchase Price Allocation | ||
Fair value of net assets acquired | $ | $( | $ | ||
Cash paid | — | ||||
Contingent consideration | $ | $— | $ | ||
Total consideration transferred | $ | $ | $ | ||
Goodwill | $ | $ | $ |
March 31, 2025 | December 31, 2024 | ||||||
(in thousands) | Carrying Value | UPB | Carrying Value | UPB | |||
Loans | |||||||
Bridge | $ | $ | $ | $ | |||
Fixed rate | |||||||
Construction | |||||||
Freddie Mac | |||||||
SBA - 7(a) | |||||||
Other | |||||||
Total Loans, net | $ | $ | $ | $ | |||
Loans in consolidated VIEs | |||||||
Bridge | |||||||
Fixed rate | |||||||
SBA - 7(a) | |||||||
Other | |||||||
Total Loans, net, in consolidated VIEs | $ | $ | $ | $ | |||
Loans, held for sale | |||||||
Bridge | |||||||
Fixed rate | |||||||
Construction | |||||||
Freddie Mac | |||||||
SBA - 7(a) | |||||||
Other | |||||||
Total Loans, held for sale | $ | $ | $ | $ | |||
Loans, held for sale in consolidated VIEs | |||||||
Bridge | |||||||
Total Loans, held for sale in consolidated VIEs | $ | $ | $ | $ | |||
Total | $ | $ | $ | $ |
Carrying Value by Year of Origination | |||||||||||||||
(in thousands) | UPB | 2025 | 2024 | 2023 | 2022 | 2021 | Pre 2021 | Total | |||||||
March 31, 2025 | |||||||||||||||
Bridge | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Fixed rate | |||||||||||||||
Construction | |||||||||||||||
Freddie Mac | |||||||||||||||
SBA - 7(a) | |||||||||||||||
Other | |||||||||||||||
Total Loans, net | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Gross write-offs | $ | $ | $ | $ | $ | $ | $ | ||||||||
UPB | 2024 | 2023 | 2022 | 2021 | 2020 | Pre 2020 | Total | ||||||||
December 31, 2024 | |||||||||||||||
Bridge | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Fixed rate | |||||||||||||||
Construction | |||||||||||||||
SBA - 7(a) | |||||||||||||||
Other | |||||||||||||||
Total Loans, net | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Gross write-offs | $ | $ | $ | $ | $ | $ | $ |
Carrying Value by Year of Origination | |||||||||||||||
(in thousands) | UPB | 2025 | 2024 | 2023 | 2022 | 2021 | Pre 2021 | Total | |||||||
March 31, 2025 | |||||||||||||||
Current | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
30 - 59 days past due | |||||||||||||||
60+ days past due | |||||||||||||||
Total Loans, net | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
UPB | 2024 | 2023 | 2022 | 2021 | 2020 | Pre 2020 | Total | ||||||||
December 31, 2024 | |||||||||||||||
Current | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
30 - 59 days past due | |||||||||||||||
60+ days past due | |||||||||||||||
Total Loans, net | $ | $ | $ | $ | $ | $ | $ | $ |
(in thousands) | Current | 30 - 59 days past due | 60+ days past due | Total | Non-Accrual Loans | 90+ days past due and Accruing | |||||
March 31, 2025 | |||||||||||
Bridge | $ | $ | $ | $ | $ | $ | |||||
Fixed rate | |||||||||||
Construction | |||||||||||
Freddie Mac | |||||||||||
SBA - 7(a) | |||||||||||
Other | |||||||||||
Total Loans, net | $ | $ | $ | $ | $ | $ | |||||
Percentage of loans outstanding | |||||||||||
December 31, 2024 | |||||||||||
Bridge | $ | $ | $ | $ | $ | $ | |||||
Fixed rate | |||||||||||
Construction | |||||||||||
SBA - 7(a) | |||||||||||
Other | |||||||||||
Total Loans, net | $ | $ | $ | $ | $ | $ | |||||
Percentage of loans outstanding |
LTV(1) | |||||||||||||
(in thousands) | 0.0 – 20.0% | 20.1 – 40.0% | 40.1 – 60.0% | 60.1 – 80.0% | 80.1 – 100.0% | Greater than 100.0% | Total | ||||||
March 31, 2025 | |||||||||||||
Bridge | $ | $ | $ | $ | $ | $ | $ | ||||||
Fixed rate | |||||||||||||
Construction | |||||||||||||
Freddie Mac | $ | ||||||||||||
SBA - 7(a) | |||||||||||||
Other | |||||||||||||
Total Loans, net | $ | $ | $ | $ | $ | $ | $ | ||||||
Percentage of loans outstanding | |||||||||||||
December 31, 2024 | |||||||||||||
Bridge | $ | $ | $ | $ | $ | $ | $ | ||||||
Fixed rate | |||||||||||||
Construction | |||||||||||||
SBA - 7(a) | |||||||||||||
Other | |||||||||||||
Total Loans, net | $ | $ | $ | $ | $ | $ | $ | ||||||
Percentage of loans outstanding |
Geographic Concentration (% of UPB) | March 31, 2025 | December 31, 2024 | |
Texas | |||
California | |||
Florida | |||
Oregon | |||
Arizona | |||
Georgia | |||
New York | |||
Illinois | |||
Washington | |||
Ohio | |||
Other | |||
Total |
Collateral Concentration (% of UPB) | March 31, 2025 | December 31, 2024 | |
Multi-family | |||
SBA | |||
Mixed Use | |||
Industrial | |||
Retail | |||
Land | |||
Office | |||
Other | |||
Total |
Collateral Concentration (% of UPB) | March 31, 2025 | December 31, 2024 | |
Lodging | |||
Gasoline Service Stations | |||
Eating Places | |||
Child Day Care Services | |||
Offices of Physicians | |||
General Freight Trucking, Local | |||
Grocery Stores | |||
Coin-Operated Laundries and Drycleaners | |||
Car Washes | |||
Assisted Living Facilities for the Elderly | |||
Other | |||
Total |
(in thousands) | Bridge | Fixed rate | Construction | SBA - 7(a) | Other | Total | |||||
March 31, 2025 | |||||||||||
General | $ | $ | $ | $ | $ | $ | |||||
Specific | |||||||||||
PCD | |||||||||||
Ending balance | $ | $ | $ | $ | $ | $ | |||||
December 31, 2024 | |||||||||||
General | $ | $ | $ | $ | $ | $ | |||||
Specific | |||||||||||
PCD | |||||||||||
Ending balance | $ | $ | $ | $ | $ | $ |
(in thousands) | Bridge | Fixed rate | Construction | SBA - 7(a) | Other | Total |
Three Months Ended March 31, 2025 | ||||||
Beginning balance | $ | $ | $ | $ | $ | $ |
Provision for (recoveries of) loan losses | ( | ( | ||||
PCD | ||||||
Charge-offs and sales | ( | ( | ( | ( | ||
Recoveries | ||||||
Ending balance | $ | $ | $ | $ | $ | $ |
Three Months Ended March 31, 2024 | ||||||
Beginning balance | $ | $ | $ | $ | $ | $ |
Provision for (recoveries of) loan losses | ( | ( | ( | ( | ( | |
Charge-offs and sales | ( | ( | ( | ( | ( | |
Recoveries | ||||||
Ending balance | $ | $ | $ | $ | $ | $ |
(in thousands) | March 31, 2025 | December 31, 2024 | |
Non-accrual loans | |||
With an allowance | $ | $ | |
Without an allowance | |||
Total recorded carrying value of non-accrual loans | $ | $ | |
Allowance for loan losses related to non-accrual loans | $( | $( | |
UPB of non-accrual loans | $ | $ | |
March 31, 2025 | March 31, 2024 | ||
Interest income on non-accrual loans for the three months ended | $ | $ |
(in thousands) | Preliminary Purchase Price Allocation |
UPB | $ |
Allowance for credit losses | ( |
Non-credit discount | ( |
Purchase price of loans classified as PCD | $ |
(in thousands) | Level 1 | Level 2 | Level 3 | Total | |||
March 31, 2025 | |||||||
Assets: | |||||||
Money market funds (1) | $ | $ | $ | $ | |||
Loans, net | |||||||
Loans, held for sale | |||||||
PPP loans (2) | |||||||
MBS | |||||||
Derivative instruments | |||||||
Investment in unconsolidated joint ventures | |||||||
Preferred equity investment (3) | |||||||
Total assets | $ | $ | $ | $ | |||
Liabilities: | |||||||
Derivative instruments | |||||||
Contingent consideration | |||||||
Total liabilities | $ | $ | $ | $ | |||
December 31, 2024 | |||||||
Assets: | |||||||
Money market funds (1) | $ | $ | $ | $ | |||
Loans, net | |||||||
Loans, held for sale | |||||||
PPP loans (2) | |||||||
MBS | |||||||
Derivative instruments | |||||||
Investment in unconsolidated joint ventures | |||||||
Preferred equity investment (3) | |||||||
Total assets | $ | $ | $ | $ | |||
Liabilities: | |||||||
Derivative instruments | |||||||
Contingent consideration | |||||||
Total liabilities | $ | $ | $ | $ |
(in thousands) | Fair Value | Predominant Valuation Technique (1) | Type | Range | Weighted Average | ||||
March 31, 2025 | |||||||||
Assets: | |||||||||
Investment in unconsolidated joint ventures | $ | Income Approach | Discount rate | ||||||
Preferred equity investment | Income Approach | Discount rate | |||||||
Total assets | $ | ||||||||
Liabilities: | |||||||||
Contingent consideration- Madison One | $ | Monte Carlo Simulation Model | Net income volatility | Risk- adjusted discount rate | ||||||
Contingent consideration - UDF | Distributable Cash Flow Approach | Discount factor | |||||||
Total liabilities | $ | ||||||||
December 31, 2024 | |||||||||
Assets: | |||||||||
Investment in unconsolidated joint ventures | $ | Income Approach | Discount rate | ||||||
Preferred equity investment | Income Approach | Discount rate | |||||||
Total assets | $ | ||||||||
Liabilities: | |||||||||
Contingent consideration- Madison One | $ | Monte Carlo Simulation Model | Net income volatility | Risk- adjusted discount rate | ||||||
Total liabilities | $ |
Three Months Ended March 31, | |||
(in thousands) | 2025 | 2024 | |
Assets: | |||
Loans, net | |||
Beginning balance | $ | $ | |
Sales / Principal payments | ( | ||
Unrealized gains (losses), net | ( | ||
Transfer to (from) Level 3 | ( | ||
Ending balance | $ | $ | |
Loans, held for sale | |||
Beginning balance | |||
Unrealized gains (losses), net | |||
Ending balance | $ | $ | |
Investment in unconsolidated joint ventures | |||
Beginning balance | |||
Unrealized gains (losses), net | ( | ( | |
Ending balance | $ | $ | |
Preferred equity investment (1) | |||
Beginning balance | |||
Unrealized gains (losses), net | ( | ||
Ending balance | $ | $ | |
Total assets | |||
Beginning balance | |||
Sales / Principal payments | ( | ||
Unrealized gains (losses), net | ( | ( | |
Transfer to (from) Level 3 | ( | ||
Ending balance | $ | $ | |
Liabilities: | |||
Contingent consideration | |||
Beginning balance | |||
Realized (gains) losses, net | ( | ||
Mergers and acquisitions (2) | $ | $ | |
Ending balance | $ | $ |
March 31, 2025 | December 31, 2024 | ||||||
(in thousands) | Carrying Value | Estimated Fair Value | Carrying Value | Estimated Fair Value | |||
Assets: | |||||||
Loans, net | $ | $ | $ | $ | |||
Loans, held for sale | |||||||
Servicing rights | |||||||
Total assets | $ | $ | $ | $ | |||
Liabilities: | |||||||
Secured borrowings | |||||||
Securitized debt obligations of consolidated VIEs, net | |||||||
Senior secured notes, net | |||||||
Guaranteed loan financing | |||||||
Corporate debt, net | |||||||
Total liabilities | $ | $ | $ | $ |
Three Months Ended March 31, | |||
(in thousands) | 2025 | 2024 | |
SBA | |||
Beginning net carrying amount | $ | $ | |
Additions | |||
Amortization | ( | ( | |
Recovery (impairment) | ( | ||
Ending net carrying amount | $ | $ | |
Multi-family | |||
Beginning net carrying amount | |||
Additions | |||
Amortization | ( | ( | |
Ending net carrying amount | $ | $ | |
USDA | |||
Beginning net carrying amount | |||
Additions | |||
Amortization | ( | ||
Recovery | |||
Ending net carrying amount | $ | $ | |
Small business loans | |||
Beginning net carrying amount | |||
Additions | |||
Amortization | ( | ||
Impairment | ( | ||
Ending net carrying amount | $ | $ | |
Total servicing rights | $ | $ |
As of March 31, 2025 | As of December 31, 2024 | ||||||
(in thousands) | UPB | Carrying Value | UPB | Carrying Value | |||
SBA | $ | $ | $ | $ | |||
Multi-family | |||||||
USDA | |||||||
Small business loans | |||||||
Total | $ | $ | $ | $ |
March 31, 2025 | December 31, 2024 | ||||||||||
Range of input values | Weighted Average | Range of input values | Weighted Average | ||||||||
SBA | |||||||||||
Forward prepayment rate | - | - | |||||||||
Forward default rate | - | - | |||||||||
Discount rate | - | - | |||||||||
Servicing expense | - | - | |||||||||
Multi-family | |||||||||||
Forward prepayment rate | - | - | |||||||||
Forward default rate | - | - | |||||||||
Discount rate | - | - | |||||||||
Servicing expense | - | - | |||||||||
USDA (1) | |||||||||||
Forward prepayment rate | - | - | |||||||||
Discount rate | - | - | |||||||||
Servicing expense | - | - | |||||||||
Small business loans (2) | |||||||||||
Discount rate | - | - | |||||||||
Servicing expense | - | - |
(in thousands) | March 31, 2025 | December 31, 2024 | |
SBA | |||
Forward prepayment rate | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
Forward default rate | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
Discount rate | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
Servicing expense | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
Multi-family | |||
Forward prepayment rate | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
Forward default rate | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
Discount rate | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
Servicing expense | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
USDA | |||
Forward prepayment rate | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
Discount rate | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
Servicing expense | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
Small business loans | |||
Discount rate | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( | |
Servicing expense | |||
Impact of 10% adverse change | $( | $( | |
Impact of 20% adverse change | $( | $( |
(in thousands) | March 31, 2025 |
2025 | $ |
2026 | |
2027 | |
2028 | |
2029 | |
Thereafter | |
Total | $ |
(in thousands) | March 31, 2025 | December 31, 2024 | |
Assets | |||
Cash and cash equivalents | $ | $ | |
Restricted cash | |||
Loans, net | |||
Loans, held for sale | |||
Loans eligible for repurchase from Ginnie Mae | |||
Servicing rights(1) | |||
Other assets | |||
Total Assets | $ | $ | |
Liabilities | |||
Secured borrowings | $ | $ | |
Liabilities for loans eligible for repurchase from Ginnie Mae | |||
Derivative instruments | |||
Accounts payable and other accrued liabilities | |||
Total Liabilities | $ | $ |
Three Months Ended March 31, | |||
(in thousands) | 2025 | 2024 | |
Interest income | $ | $ | |
Interest expense | ( | ( | |
Net interest expense | $ | $( | |
Non-interest income | |||
Residential mortgage banking activities | |||
Net realized gain (loss) on financial instruments | |||
Net unrealized gain (loss) on financial instruments | ( | ||
Servicing income, net of amortization and impairment | |||
Other income | |||
Total non-interest income | $ | $ | |
Non-interest expense | |||
Employee compensation and benefits | ( | ( | |
Variable expenses on residential mortgage banking activities | ( | ( | |
Professional fees | ( | ( | |
Loan servicing expense | ( | ( | |
Other operating expenses | ( | ( | |
Total non-interest expense | $( | $( | |
Income (loss) from discontinued operations before provision for income taxes | ( | ||
Income tax (provision) benefit | ( | ||
Net income (loss) from discontinued operations | $( | $ |
Pledged Assets | Carrying Value at | |||||||||
Lenders (1) | Asset Class | Current Maturity (2) | Pricing (3) | Facility Size | Carrying Value | March 31, 2025 | December 31, 2024 | |||
3 | SBA loans | June 2025 - March 2026 | SOFR + Prime - | $ | $ | $ | $ | |||
1 | LMM loans - USD | February 2026 | SOFR + | |||||||
1 | LMM loans - Non-USD (4) | January 2027 | EURIBOR + | |||||||
Total borrowings under credit facilities and other financing agreements | $ | $ | $ | $ | ||||||
8 | LMM loans | July 2025 - July 2027 | SOFR + | |||||||
5 | MBS | April 2025 - July 2025 | ||||||||
Total borrowings under repurchase agreements | $ | $ | $ | $ | ||||||
Total secured borrowings | $ | $ | $ | $ |
Pledged Assets Carrying Value | |||
(in thousands) | March 31, 2025 | December 31, 2024 | |
Collateral pledged - borrowings under credit facilities and other financing agreements | |||
Loans, held for sale | $ | $ | |
Loans, net | |||
Total | $ | $ | |
Collateral pledged - borrowings under repurchase agreements | |||
Loans, net | |||
MBS | |||
Retained interest in assets of consolidated VIEs | |||
Loans, held for sale | |||
Real estate acquired in settlement of loans | |||
Total | $ | $ | |
Total collateral pledged on secured borrowings | $ | $ |
(in thousands) | Coupon Rate | Maturity Date | March 31, 2025 | ||
Senior secured notes principal amount(1) | 10/20/2026 | $ | |||
Senior secured notes principal amount(2) | 3/1/2028 | ||||
Term loan principal amount(3) | SOFR + | 4/12/2029 | |||
Unamortized discount | ( | ||||
Unamortized deferred financing costs | ( | ||||
Total senior secured notes, net | $ | ||||
Corporate debt principal amount(4) | 12/30/2028 | ||||
Corporate debt principal amount(5) | 7/30/2026 | ||||
Corporate debt principal amount(5) | 2/15/2026 | ||||
Corporate debt principal amount(6) | 4/30/2025 | ||||
Corporate debt principal amount(7) | 7/31/2027 | ||||
Corporate debt principal amount(8) | 11/15/2026 | ||||
Corporate debt principal amount(9) | 12/15/2029 | ||||
Unamortized discount - corporate debt | ( | ||||
Unamortized deferred financing costs - corporate debt | ( | ||||
Junior subordinated notes principal amount(10) | SOFR + | 3/30/2035 | |||
Junior subordinated notes principal amount(11) | SOFR + | 4/30/2035 | |||
Total corporate debt, net | $ | ||||
Total carrying amount of debt | $ |
(in thousands) | March 31, 2025 |
2025 | $ |
2026 | |
2027 | |
2028 | |
2029 | |
Thereafter | |
Total contractual amounts | $ |
Unamortized deferred financing costs, discounts, and premiums, net | ( |
Total carrying amount of debt | $ |
(in thousands) | Weighted Average Interest Rate | Range of Interest Rates | Range of Maturities (Years) | Ending Balance | |||
March 31, 2025 | 2025-2048 | $ | |||||
December 31, 2024 | 2025-2048 | $ |
(in thousands) | March 31, 2025 |
2025 | $ |
2026 | |
2027 | |
2028 | |
2029 | |
Thereafter | |
Total | $ |
(in thousands) | March 31, 2025 | December 31, 2024 | |
Assets: | |||
Cash and cash equivalents | $ | $ | |
Restricted cash | |||
Loans, net | |||
Loans, held for sale | |||
Preferred equity investment (1) | |||
Accrued interest (1) | |||
Other assets | |||
Total assets | $ | $ | |
Liabilities: | |||
Securitized debt obligations of consolidated VIEs, net | |||
Due to third parties (2) | |||
Accounts payable and other accrued liabilities (2) | |||
Total liabilities | $ | $ |
March 31, 2025 | December 31, 2024 | ||||||||||
(in thousands) | Current Principal Balance | Carrying value | Weighted Average Interest Rate | Current Principal Balance | Carrying value | Weighted Average Interest Rate | |||||
ReadyCap Lending Small Business Trust 2019-2 | $ | $ | $ | $ | |||||||
ReadyCap Lending Small Business Trust 2023-3 | |||||||||||
Sutherland Commercial Mortgage Trust 2019-SBC8 | |||||||||||
Sutherland Commercial Mortgage Trust 2021-SBC10 | |||||||||||
ReadyCap Commercial Mortgage Trust 2016-3 | |||||||||||
ReadyCap Commercial Mortgage Trust 2018-4 | |||||||||||
ReadyCap Commercial Mortgage Trust 2019-5 | |||||||||||
ReadyCap Commercial Mortgage Trust 2019-6 | |||||||||||
ReadyCap Commercial Mortgage Trust 2022-7 | |||||||||||
Ready Capital Mortgage Financing 2021-FL5 | |||||||||||
Ready Capital Mortgage Financing 2021-FL6 | |||||||||||
Ready Capital Mortgage Financing 2021-FL7 | |||||||||||
Ready Capital Mortgage Financing 2022-FL8 | |||||||||||
Ready Capital Mortgage Financing 2022-FL9 | |||||||||||
Ready Capital Mortgage Financing 2022-FL10 | |||||||||||
Ready Capital Mortgage Financing 2023-FL11 | |||||||||||
Ready Capital Mortgage Financing 2023-FL12 | |||||||||||
Total | $ | $ | $ | $ |
Carrying Amount | Maximum Exposure to Loss (1) | ||||||
(in thousands) | March 31, 2025 | December 31, 2024 | March 31, 2025 | December 31, 2024 | |||
MBS (2) | $ | $ | $ | $ | |||
Investment in unconsolidated joint ventures | |||||||
Total assets in unconsolidated VIEs | $ | $ | $ | $ |
Three Months Ended March 31, | |||
(in thousands) | 2025 | 2024 | |
Interest income | |||
Loans, net | |||
Bridge | $ | $ | |
Fixed rate | |||
Construction | |||
SBA - 7(a) | |||
PPP (1) | |||
Other | |||
Total loans, net (2) | $ | $ | |
Loans, held for sale | |||
Fixed rate | |||
Construction | |||
SBA - 7(a) | |||
Other | |||
Total loans, held for sale (2) | $ | $ | |
Loans, held at fair value | |||
Other | |||
Total loans, held at fair value | $ | $ | |
Investments held to maturity (1) | |||
Preferred equity investment (2) | |||
MBS | |||
Total interest income | $ | $ | |
Interest expense | |||
Secured borrowings | ( | ( | |
PPPLF borrowings (3) | ( | ( | |
Securitized debt obligations of consolidated VIEs | ( | ( | |
Guaranteed loan financing | ( | ( | |
Senior secured notes | ( | ( | |
Corporate debt | ( | ( | |
Total interest expense | $( | $( | |
Net interest income before provision for loan losses | $ | $ |
March 31, 2025 | December 31, 2024 | |||||||||||
(in thousands) | Primary Underlying Risk | Notional Amount | Derivative Asset | Derivative Liability | Notional Amount | Derivative Asset | Derivative Liability | |||||
Interest Rate Swaps - not designated as hedges | Interest rate risk | $ | $ | $ | $ | $ | ||||||
Interest Rate Swaps - designated as hedges | Interest rate risk | ( | ||||||||||
FX forwards | Foreign exchange rate risk | ( | ( | |||||||||
Total | $ | $ | $( | $ | $ | $( |
(in thousands) | Net Realized Gain (Loss) | Net Unrealized Gain (Loss) | |
Three Months Ended March 31, 2025 | |||
Interest rate swaps | $ | $( | |
Total | $ | $( | |
Three Months Ended March 31, 2024 | |||
Interest rate swaps | $ | $ | |
Total | $ | $ |
(in thousands) | Derivatives - effective portion reclassified from AOCI to income | Derivatives - effective portion recorded in OCI | Total change in OCI for period | ||
Interest rate swaps | |||||
Three Months Ended March 31, 2025 | $( | $( | $( | ||
Three Months Ended March 31, 2024 | $( | $ | $ |
(in thousands) | March 31, 2025 | December 31, 2024 | |
Acquired Portfolio: | |||
Mixed use | $ | $ | |
Multi-family | |||
Lodging | |||
Residential | |||
Office | |||
Land | |||
Total Acquired REO | $ | $ | |
Other REO Held for Sale: | |||
Office | |||
Mixed use | |||
Multi-family | |||
Other | |||
Total Other REO | $ | $ | |
Total real estate owned, held for sale | $ | $ |
Three Months Ended March 31, | |||
2025 | 2024 | ||
Management fee - total | $ | $ | |
Management fee - amount unpaid | $ | $ |
Three Months Ended March 31, | |||
2025 | 2024 | ||
Incentive fee distribution - total | $ | $ | |
Incentive fee distribution - amount unpaid | $ | $ |
Three Months Ended March 31, | |||
2025 | 2024 | ||
Reimbursable expenses payable to Manager - total | $ | $ | |
Reimbursable expenses payable to Manager - amount unpaid | $ | $ |
(in thousands) | March 31, 2025 | December 31, 2024 | |
Other assets: | |||
Goodwill | $ | $ | |
Deferred loan exit fees | |||
Accrued interest | |||
Due from servicers | |||
Intangible assets | |||
Receivable from third party | |||
Deferred financing costs | |||
Deferred tax asset | |||
Tax receivable | |||
Right-of-use lease asset | |||
PPP receivables | |||
Investments held to maturity | |||
Other | |||
Other assets | $ | $ | |
Accounts payable and other accrued liabilities: | |||
Accrued salaries, wages and commissions | |||
Accrued interest payable | |||
Servicing principal and interest payable | |||
Repair and denial reserve | |||
Payable to related parties | |||
PPP liabilities | |||
Accrued professional fees | |||
Lease payable | |||
Liabilities of consolidated VIEs | |||
Other | |||
Total accounts payable and other accrued liabilities | $ | $ |
(in thousands) | March 31, 2025 | December 31, 2024 | |
LMM Commercial Real Estate | $ | $ | |
Small Business Lending | |||
Total | $ | $ |
(in thousands) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Value | ||
March 31, 2025 | |||||
Amortized intangible assets: | |||||
Internally developed software | $ | $ | $ | ||
Customer relationships | |||||
Broker network | |||||
Other | |||||
Unamortized intangible assets: | |||||
Trade name | — | ||||
SBA license | — | ||||
Total intangible assets | $ | $ | $ | ||
December 31, 2024 | |||||
Amortized intangible assets: | |||||
Internally developed software | $ | $ | $ | ||
Customer relationships | |||||
Broker network | |||||
Other | |||||
Unamortized intangible assets: | |||||
Trade name | — | ||||
SBA license | — | ||||
Total intangible assets | $ | $ | $ |
(in thousands) | March 31, 2025 |
2025 | $ |
2026 | |
2027 | |
2028 | |
2029 | |
Thereafter | |
Total | $ |
Three Months Ended March 31, | |||
(in thousands) | 2025 | 2024 | |
Other income: | |||
Origination income | $ | $ | |
Change in repair and denial reserve | ( | ( | |
ERC consulting income | |||
Other | |||
Total other income | $ | $ | |
Other operating expenses: | |||
Origination costs | |||
Technology expense | |||
Rent and property tax expense | |||
Recruiting, training and travel expense | |||
Marketing expense | |||
Bad debt expense - ERC | |||
Other | |||
Total other operating expenses | $ | $ |
Declaration Date | Record Date | Payment Date | Dividend per Share | |||
March 15, 2024 | March 28, 2024 | April 30, 2024 | $ | |||
June 14, 2024 | June 28, 2024 | July 31, 2024 | $ | |||
September 13, 2024 | September 30, 2024 | October 31, 2024 | $ | |||
December 13, 2024 | December 31, 2024 | January 31, 2025 | $ | |||
March 3, 2025 | March 31, 2025 | April 30, 2025 | $ |
Restricted Stock Units/Awards | |||||
(in thousands, except share data) | Number of shares | Grant date fair value | Weighted-average grant date fair value (per share) | ||
Outstanding, December 31, 2024 | $ | $ | |||
Granted | |||||
Vested | ( | ( | |||
Forfeited | ( | ( | |||
Outstanding, March 31, 2025 | $ | $ |
Preferential Cash Dividends | Carrying Value (in thousands) | ||||||||||
Series | Shares Issued and Outstanding (in thousands) | Par Value | Liquidation Preference | Rate per Annum | Annual Dividend (per share) | March 31, 2025 | |||||
C | $ | $ | $ | ||||||||
E | $ | $ | $ |
Three Months Ended March 31, | |||
(in thousands, except for share and per share amounts) | 2025 | 2024 | |
Basic Earnings | |||
Net income (loss) from continuing operations | $ | $( | |
Less: Income attributable to non-controlling interest | |||
Less: Income attributable to participating shares | |||
Basic earnings - continuing operations | $ | $( | |
Basic earnings - discontinued operations | $( | $ | |
Diluted Earnings | |||
Net income (loss) from continuing operations | ( | ||
Less: Income attributable to non-controlling interest | |||
Less: Income attributable to participating shares | |||
Add: Expenses attributable to dilutive instruments | |||
Diluted earnings - continuing operations | $ | $( | |
Diluted earnings - discontinued operations | $( | $ | |
Number of Shares | |||
Basic — Average shares outstanding | |||
Effect of dilutive securities — Unvested participating shares | |||
Diluted — Average shares outstanding | |||
EPS Attributable to RC Common Stockholders: | |||
Basic - continuing operations | $ | $( | |
Basic - discontinued operations | $ | $ | |
Basic - total | $ | $( | |
Diluted - continuing operations | $ | $( | |
Diluted - discontinued operations | $ | $ | |
Diluted - total | $ | $( |
Gross amounts not offset in the Consolidated Balance Sheets(1) | |||||||||||
(in thousands) | Gross amounts of Assets / Liabilities | Gross amounts offset | Balance in Consolidated Balance Sheets | Financial Instruments | Cash Collateral Received / Paid | Net Amount | |||||
March 31, 2025 | |||||||||||
Assets | |||||||||||
FX forwards | $ | $ | $ | $ | $ | $ | |||||
Interest rate swaps | |||||||||||
Total | $ | $ | $ | $ | $ | $ | |||||
Liabilities | |||||||||||
Interest rate swaps | |||||||||||
FX forwards | |||||||||||
Secured borrowings | |||||||||||
PPPLF | |||||||||||
Total | $ | $ | $ | $ | $ | $ | |||||
December 31, 2024 | |||||||||||
Assets | |||||||||||
FX forwards | |||||||||||
Interest rate swaps | |||||||||||
Total | $ | $ | $ | $ | $ | $ | |||||
Liabilities | |||||||||||
FX forwards | |||||||||||
Secured borrowings | |||||||||||
PPPLF | |||||||||||
Total | $ | $ | $ | $ | $ | $ |
(in thousands) | March 31, 2025 | December 31, 2024 | |
Loans, net | $ | $ | |
Loans, held for sale | $ | $ |
Three Months Ended March 31, 2025 | |||||
(in thousands) | LMM Commercial Real Estate | Small Business Lending | Total | ||
Interest income | $ | $ | $ | ||
Interest expense | ( | ( | ( | ||
Net interest income before recovery of (provision for) loan losses | $ | $ | $ | ||
Recovery of (provision for) loan losses | ( | ||||
Net interest income after recovery of (provision for) loan losses | $ | $ | $ | ||
Non-interest income | |||||
Net realized gain (loss) on financial instruments and real estate owned | ( | ||||
Net unrealized gain (loss) on financial instruments | ( | ( | ( | ||
Valuation allowance, loans held for sale | ( | ( | |||
Servicing income, net | |||||
Income (loss) on unconsolidated joint ventures | ( | ( | |||
Other income | |||||
Total non-interest income (loss) | $( | $ | $( | ||
Non-interest expense | |||||
Employee compensation and benefits | ( | ( | ( | ||
Allocated employee compensation and benefits from related party | ( | ( | |||
Professional fees | ( | ( | ( | ||
Loan servicing expense | ( | ( | ( | ||
Impairment on real estate | ( | ( | |||
Other operating expenses | ( | ( | ( | ||
Total non-interest expense | $( | $( | $( | ||
Income (loss) before unallocated expenses and provision for income taxes | $( | $ | $( | ||
Unallocated corporate income (expenses) | |||||
Gain on bargain purchase | |||||
Employee compensation and benefits | ( | ||||
Professional fees | ( | ||||
Management fees – related party | ( | ||||
Transaction related expenses | ( | ||||
Other operating expenses - net | ( | ||||
Total unallocated corporate expenses | $ | ||||
Income before provision for income taxes | $ | ||||
Total assets | $ | $ | $ |
Three Months Ended March 31, 2024 | |||||
(in thousands) | LMM Commercial Real Estate | Small Business Lending | Total | ||
Interest income | $ | $ | $ | ||
Interest expense | ( | ( | ( | ||
Net interest income before recovery of (provision for) loan losses | $ | $ | $ | ||
Recovery of (provision for) loan losses | ( | ||||
Net interest income after recovery of (provision for) loan losses | $ | $ | $ | ||
Non-interest income | |||||
Net realized gain (loss) on financial instruments and real estate owned | |||||
Net unrealized gain (loss) on financial instruments | |||||
Valuation allowance, loans held for sale | ( | ( | |||
Servicing income, net | |||||
Income on unconsolidated joint ventures | |||||
Other income | |||||
Total non-interest income | $( | $ | $( | ||
Non-interest expense | |||||
Employee compensation and benefits | ( | ( | ( | ||
Allocated employee compensation and benefits from related party | ( | ( | |||
Professional fees | ( | ( | ( | ||
Loan servicing expense | ( | ( | ( | ||
Impairment on real estate | ( | ( | |||
Other operating expenses | ( | ( | ( | ||
Total non-interest expense | $( | $( | $( | ||
Income (loss) before unallocated expenses and provision for income taxes | $( | $ | $( | ||
Unallocated corporate income (expenses) | |||||
Employee compensation and benefits | ( | ||||
Professional fees | ( | ||||
Management fees – related party | ( | ||||
Transaction related expenses | ( | ||||
Other operating expenses - net | ( | ||||
Total unallocated corporate income | $( | ||||
Loss before provision for income taxes | $( | ||||
Total assets | $ | $ | $ |
Three Months Ended March 31, | |||
($ in thousands, except share data) | 2025 | 2024 | |
Net Income (loss) from continuing operations | $82,410 | $(75,582) | |
Earnings per common share from continuing operations - basic | $0.47 | $(0.45) | |
Earnings per common share from continuing operations - diluted | $0.46 | $(0.45) | |
Distributable earnings before realized losses | $4,140 | $53,976 | |
Distributable earnings before realized losses per common share - basic | $0.00 | $0.29 | |
Distributable earnings before realized losses per common share - diluted | $0.00 | $0.29 | |
Distributable earnings | $(11,384) | $53,976 | |
Distributable earnings per common share - basic | $(0.09) | $0.29 | |
Distributable earnings per common share - diluted | $(0.09) | $0.29 | |
Dividends declared per common share | $0.125 | $0.30 | |
Dividend yield (1) | 9.8% | 13.1% | |
Return on equity from continuing operations | 18.4% | (13.3)% | |
Distributable return on equity before realized losses | (0.9)% | 8.6% | |
Distributable return on equity | (3.1)% | 8.6% | |
Book value per common share | $10.61 | $13.44 |
Three Months Ended March 31, | |||
(in thousands) | 2025 | 2024 | |
Loan originations: | |||
LMM loans | $78,657 | $259,676 | |
SBL loans | 387,388 | 197,159 | |
Total loan investment activity | $466,045 | $456,835 |
(in thousands) | March 31, 2025 | December 31, 2024 | $ Change | % Change | |||
Assets | |||||||
Cash and cash equivalents | $205,917 | $143,803 | $62,114 | 43.2% | |||
Restricted cash | 39,603 | 30,560 | 9,043 | 29.6 | |||
Loans, net (including $2,018 and $3,533 held at fair value) | 4,354,017 | 3,378,149 | 975,868 | 28.9 | |||
Loans, held for sale (including $81,789 and $128,531 held at fair value and net of valuation allowance of $158,068 and $97,620) | 528,726 | 241,626 | 287,100 | 118.8 | |||
Mortgage-backed securities | 31,415 | 31,006 | 409 | 1.3 | |||
Investment in unconsolidated joint ventures (including $6,371 and $6,577 held at fair value) | 170,920 | 161,561 | 9,359 | 5.8 | |||
Derivative instruments | 6,907 | 7,963 | (1,056) | (13.3) | |||
Servicing rights | 129,814 | 128,440 | 1,374 | 1.1 | |||
Real estate owned, held for sale | 199,910 | 193,437 | 6,473 | 3.3 | |||
Other assets | 399,702 | 362,486 | 37,216 | 10.3 | |||
Assets of consolidated VIEs | 3,723,738 | 5,175,295 | (1,451,557) | (28.0) | |||
Assets held for sale | 185,782 | 287,595 | (101,813) | (35.4) | |||
Total Assets | $9,976,451 | $10,141,921 | $(165,470) | (1.6)% | |||
Liabilities | |||||||
Secured borrowings | 2,713,415 | 2,035,176 | 678,239 | 33.3 | |||
Securitized debt obligations of consolidated VIEs, net | 2,574,139 | 3,580,513 | (1,006,374) | (28.1) | |||
Senior secured notes, net | 671,510 | 437,847 | 233,663 | 53.4 | |||
Corporate debt, net | 817,156 | 895,265 | (78,109) | (8.7) | |||
Guaranteed loan financing | 668,847 | 691,118 | (22,271) | (3.2) | |||
Contingent consideration | 15,982 | 573 | 15,409 | 2,689.2 | |||
Derivative instruments | 575 | 352 | 223 | 63.4 | |||
Dividends payable | 23,929 | 43,168 | (19,239) | (44.6) | |||
Loan participations sold | 98,128 | 95,578 | 2,550 | 2.7 | |||
Due to third parties | 1,071 | 1,442 | (371) | (25.7) | |||
Accounts payable and other accrued liabilities | 185,533 | 188,051 | (2,518) | (1.3) | |||
Liabilities held for sale | 156,614 | 228,735 | (72,121) | (31.5) | |||
Total Liabilities | $7,926,899 | $8,197,818 | $(270,919) | (3.3)% | |||
Preferred stock Series C, liquidation preference $25.00 per share | 8,361 | 8,361 | — | — | |||
Commitments & contingencies | |||||||
Stockholders’ Equity | |||||||
Preferred stock Series E, liquidation preference $25.00 per share | 111,378 | 111,378 | — | — | |||
Common stock, $0.0001 par value, 500,000,000 shares authorized, 172,507,227 and 162,792,372 shares issued and outstanding, respectively | 17 | 17 | — | — | |||
Additional paid-in capital | 2,302,101 | 2,250,291 | 51,810 | 2.3 | |||
Retained earnings (deficit) | (450,276) | (505,089) | 54,813 | (10.9) | |||
Accumulated other comprehensive loss | (21,673) | (18,552) | (3,121) | (16.8) | |||
Total Ready Capital Corporation equity | 1,941,547 | 1,838,045 | 103,502 | 5.6 | |||
Non-controlling interests | 99,644 | 97,697 | 1,947 | 2.0 | |||
Total Stockholders’ Equity | $2,041,191 | $1,935,742 | $105,449 | 5.4% | |||
Total Liabilities, Redeemable Preferred Stock, and Stockholders’ Equity | $9,976,451 | $10,141,921 | $(165,470) | (1.6)% |
(in thousands) | LMM Commercial Real Estate | Small Business Lending | Total | ||
March 31, 2025 | |||||
Assets | |||||
Loans, net | $6,424,889 | $1,261,188 | $7,686,077 | ||
Loans, held for sale | 621,393 | 75,748 | 697,141 | ||
MBS | 31,415 | — | 31,415 | ||
Investment in unconsolidated joint ventures | 170,376 | 544 | 170,920 | ||
Servicing rights | 65,139 | 64,675 | 129,814 | ||
Real estate owned, held for sale | 218,006 | 32 | 218,038 | ||
Liabilities | |||||
Secured borrowings | 2,456,284 | 257,131 | 2,713,415 | ||
Securitized debt obligations of consolidated VIEs | 2,469,714 | 104,425 | 2,574,139 | ||
Senior secured notes, net | 663,891 | 7,619 | 671,510 | ||
Corporate debt, net | 817,156 | — | 817,156 | ||
Guaranteed loan financing | — | 668,847 | 668,847 | ||
Loan participations sold | 98,128 | — | 98,128 |
Three Months Ended March 31, | |||||
(in thousands) | 2025 | 2024 | $ Change | ||
Interest income | |||||
LMM commercial real estate | $124,973 | $200,763 | $(75,790) | ||
Small business lending | 29,994 | 31,591 | (1,597) | ||
Total interest income | $154,967 | $232,354 | $(77,387) | ||
Interest expense | |||||
LMM commercial real estate | (120,354) | (158,885) | 38,531 | ||
Small business lending | (20,112) | (24,920) | 4,808 | ||
Total interest expense | $(140,466) | $(183,805) | $43,339 | ||
Net interest income before recovery of (provision for) loan losses | $14,501 | $48,549 | $(34,048) | ||
Recovery of (provision for) loan losses | |||||
LMM commercial real estate | 117,941 | 30,755 | 87,186 | ||
Small business lending | (8,373) | (4,211) | (4,162) | ||
Total recovery of (provision for) loan losses | $109,568 | $26,544 | $83,024 | ||
Net interest income after recovery of (provision for) loan losses | $124,069 | $75,093 | $48,976 | ||
Non-interest income (loss) | |||||
LMM commercial real estate | (114,475) | (122,946) | 8,471 | ||
Small business lending | 36,449 | 20,318 | 16,131 | ||
Unallocated corporate income | 103,762 | — | 103,762 | ||
Total non-interest income (loss) | $25,736 | $(102,628) | $128,364 | ||
Non-interest expense | |||||
LMM commercial real estate | (27,763) | (43,448) | 15,685 | ||
Small business lending | (30,060) | (18,107) | (11,953) | ||
Unallocated corporate expenses | (14,779) | (16,703) | 1,924 | ||
Total non-interest expense | $(72,602) | $(78,258) | $5,656 | ||
Net income (loss) before provision for income taxes | |||||
LMM commercial real estate | (19,678) | (93,761) | 74,083 | ||
Small business lending | 7,898 | 4,671 | 3,227 | ||
Unallocated corporate expenses | 88,983 | (16,703) | 105,686 | ||
Total net income (loss) before provision for income taxes | $77,203 | $(105,793) | $182,996 |
Three Months Ended March 31, | |||||
(in thousands) | 2025 | 2024 | $ Change | ||
Realized gain (loss) on financial instruments | |||||
Creation of mortgage servicing rights | |||||
SBA - 7(a) | $4,859 | $2,683 | $2,176 | ||
Multi-family | 515 | 1,733 | (1,218) | ||
USDA | 750 | — | 750 | ||
Small business loans | 544 | — | 544 | ||
Total Creation of mortgage servicing rights | $6,668 | $4,416 | $2,252 | ||
Loans | |||||
SBA - 7(a) | 18,937 | 10,435 | 8,502 | ||
Multi-family | 413 | 347 | 66 | ||
USDA | 179 | — | 179 | ||
Total loans | $19,529 | $10,782 | $8,747 | ||
Gain on sale business | |||||
SBA - 7(a) | 23,796 | 13,118 | 10,678 | ||
Multi-family | 928 | 2,080 | (1,152) | ||
USDA | 929 | — | 929 | ||
Small business loans | 544 | — | 544 | ||
Total gain on sale business | $26,197 | $15,198 | $10,999 | ||
Loans, held for sale | |||||
Bridge | (16,885) | — | (16,885) | ||
Construction | (19) | — | (19) | ||
Total loans, held for sale | $(16,904) | $— | $(16,904) | ||
Loans, net | |||||
Bridge | (393) | 328 | (721) | ||
Fixed rate | (13) | — | (13) | ||
Construction | (145) | (241) | 96 | ||
Other | (70) | (370) | 300 | ||
Total loans, net | $(621) | $(283) | $(338) | ||
Net realized gain (loss) on derivatives, at fair value | $1,946 | $4,392 | $(2,446) | ||
Net realized gain (loss) - all other | $51 | $(439) | $490 | ||
Net realized gain (loss) on financial instruments | $10,669 | $18,868 | $(8,199) | ||
Unrealized gain (loss) on financial instruments | |||||
Loans, held for sale | |||||
Fixed rate | 10 | — | 10 | ||
Freddie Mac | (309) | (141) | (168) | ||
SBA - 7(a) | (1,169) | 1,645 | (2,814) | ||
Other | — | 293 | (293) | ||
Total Loans, held for sale | $(1,468) | $1,797 | $(3,265) | ||
Net unrealized gain (loss) on derivatives, at fair value | $(515) | $376 | $(891) | ||
Net unrealized gain (loss) - all other | $233 | $2,459 | $(2,226) | ||
Net unrealized gain (loss) on financial instruments | $(1,750) | $4,632 | $(6,382) |
Three Months Ended March 31, | |||||
(in thousands) | 2025 | 2024 | $ Change | ||
Net Income (loss) | $81,965 | $(74,167) | $156,132 | ||
Reconciling items: | |||||
Unrealized (gain) loss on MSR - discontinued operations | 8,952 | — | 8,952 | ||
Unrealized (gain) loss on joint ventures | 5,639 | (35) | 5,674 | ||
Increase (decrease) in CECL reserve | (112,127) | (32,181) | (79,946) | ||
Increase (decrease) in valuation allowance | 99,718 | 146,180 | (46,462) | ||
Non-recurring REO impairment | 2,346 | 15,512 | (13,166) | ||
Non-cash compensation | 1,785 | 1,877 | (92) | ||
Merger transaction costs and other non-recurring expenses | 2,993 | 1,931 | 1,062 | ||
Bargain purchase (gain) loss | (102,471) | — | (102,471) | ||
Realized losses on sale of investments | 20,084 | — | 20,084 | ||
Total reconciling items | $(73,081) | $133,284 | $(206,365) | ||
Income tax adjustments | (4,744) | (5,141) | 397 | ||
Distributable earnings before realized losses | $4,140 | $53,976 | $(49,836) | ||
Realized losses on sale of investments, net of tax | (15,524) | — | (15,524) | ||
Distributable earnings | $(11,384) | $53,976 | $(65,360) | ||
Less: Distributable earnings attributable to non-controlling interests | 1,985 | 1,108 | 877 | ||
Less: Income attributable to participating shares | 2,228 | 2,335 | (107) | ||
Distributable earnings attributable to common stockholders | $(15,597) | $50,533 | $(66,130) | ||
Distributable earnings before realized losses on investments, net of tax per common share - basic | $0.00 | $0.29 | $(0.29) | ||
Distributable earnings before realized losses on investments, net of tax per common share - diluted | $0.00 | $0.29 | $(0.29) | ||
Distributable earnings per common share - basic | $(0.09) | $0.29 | $(0.38) | ||
Distributable earnings per common share - diluted | $(0.09) | $0.29 | $(0.38) |
Pledged Assets | Carrying Value at | |||||||||
Lenders (1) | Asset Class | Current Maturity (2) | Pricing (3) | Facility Size | Carrying Value | March 31, 2025 | December 31, 2024 | |||
3 | SBA loans | June 2025 - March 2026 | SOFR + 2.83% Prime - 0.82% | $260,000 | $334,153 | $257,131 | $250,601 | |||
1 | LMM loans - USD | February 2026 | SOFR + 1.35% | 80,000 | 3,281 | 3,273 | 35,931 | |||
1 | LMM loans - Non-USD (4) | January 2027 | EURIBOR + 3.00% | 54,081 | 34,395 | 27,753 | 30,513 | |||
Total borrowings under credit facilities and other financing agreements | $394,081 | $371,829 | $288,157 | $317,045 |
Pledged Assets | Carrying Value at | |||||||||
Lenders (1) | Asset Class | Current Maturity (2) | Pricing (3) | Facility Size | Carrying Value | March 31, 2025 | December 31, 2024 | |||
8 | LMM loans | July 2025 - July 2027 | SOFR + 2.91% | $3,866,411 | $3,102,177 | $2,209,018 | $1,482,085 | |||
5 | MBS | April 2025 - July 2025 | 7.22% | 216,240 | 403,193 | 216,240 | 236,046 | |||
Total borrowings under repurchase agreements | $4,082,651 | $3,505,370 | $2,425,258 | $1,718,131 |
(in thousands) | Quarter End Balance | Average Balance in Quarter | Highest Month End Balance in Quarter | ||
Q2 2023 | 1,792,366 | 1,945,290 | 2,022,433 | ||
Q3 2023 | 1,915,878 | 1,876,204 | 1,915,879 | ||
Q4 2023 | 1,952,152 | 1,889,494 | 1,952,152 | ||
Q1 2024 | 1,998,132 | 1,956,153 | 1,998,132 | ||
Q2 2024 | 2,087,661 | 2,058,766 | 2,087,661 | ||
Q3 2024 | 1,882,327 | 1,971,347 | 2,049,273 | ||
Q4 2024 | 1,718,131 | 1,795,627 | 1,846,677 | ||
Q1 2025 | 2,425,258 | 1,922,525 | 2,425,258 |
(in thousands) | Coupon Rate | Maturity Date | March 31, 2025 | ||
Senior secured notes principal amount(1) | 4.50% | 10/20/2026 | $350,000 | ||
Senior secured notes principal amount(2) | 9.375% | 3/1/2028 | 220,000 | ||
Term loan principal amount(3) | SOFR + 5.50% | 4/12/2029 | 115,250 | ||
Unamortized discount | (2,314) | ||||
Unamortized deferred financing costs | (11,426) | ||||
Total senior secured notes, net | $671,510 | ||||
Corporate debt principal amount(4) | 5.50% | 12/30/2028 | 110,000 | ||
Corporate debt principal amount(5) | 6.20% | 7/30/2026 | 90,081 | ||
Corporate debt principal amount(5) | 5.75% | 2/15/2026 | 158,900 | ||
Corporate debt principal amount(6) | 6.125% | 4/30/2025 | 102,426 | ||
Corporate debt principal amount(7) | 7.375% | 7/31/2027 | 100,000 | ||
Corporate debt principal amount(8) | 5.00% | 11/15/2026 | 100,000 | ||
Corporate debt principal amount(9) | 9.00% | 12/15/2029 | 130,000 | ||
Unamortized discount - corporate debt | (7,380) | ||||
Unamortized deferred financing costs - corporate debt | (3,121) | ||||
Junior subordinated notes principal amount(10) | SOFR + 3.10% | 3/30/2035 | 15,000 | ||
Junior subordinated notes principal amount(11) | SOFR + 3.10% | 4/30/2035 | 21,250 | ||
Total corporate debt, net | $817,156 | ||||
Total carrying amount of debt | $1,488,666 |
(in thousands) | March 31, 2025 |
2025 | $102,426 |
2026 | 698,981 |
2027 | 100,000 |
2028 | 330,000 |
2029 | 245,250 |
Thereafter | 36,250 |
Total contractual amounts | $1,512,907 |
Unamortized deferred financing costs, discounts, and premiums, net | (24,241) |
Total carrying amount of debt | $1,488,666 |
(in millions) | Collateral Asset Class | Issuance | Active / Collapsed | Bonds Issued |
Trusts (Firm sponsored) | ||||
Waterfall Victoria Mortgage Trust 2011-1 (SBC1) | LMM Acquired loans | February 2011 | Collapsed | $40.5 |
Waterfall Victoria Mortgage Trust 2011-3 (SBC3) | LMM Acquired loans | October 2011 | Collapsed | 143.4 |
Sutherland Commercial Mortgage Trust 2015-4 (SBC4) | LMM Acquired loans | August 2015 | Collapsed | 125.4 |
Sutherland Commercial Mortgage Trust 2018 (SBC7) | LMM Acquired loans | November 2018 | Collapsed | 217.0 |
ReadyCap Lending Small Business Trust 2015-1 (RCLT 2015-1) | Acquired SBA 7(a) loans | June 2015 | Collapsed | 189.5 |
ReadyCap Lending Small Business Loan Trust 2019-2 (RCLT 2019-2) | Originated SBA 7(a) loans, Acquired SBA 7(a) loans | December 2019 | Active | 131.0 |
ReadyCap Lending Small Business Loan Trust 2023-3 (RCLT 2023-3) | Originated SBA 7(a) loans, Acquired SBA 7(a) loans | July 2023 | Active | 132.0 |
Real Estate Mortgage Investment Conduits (REMICs) | ||||
ReadyCap Commercial Mortgage Trust 2014-1 (RCMT 2014-1) | LMM Originated conventional | September 2014 | Collapsed | 181.7 |
ReadyCap Commercial Mortgage Trust 2015-2 (RCMT 2015-2) | LMM Originated conventional | November 2015 | Collapsed | 218.8 |
ReadyCap Commercial Mortgage Trust 2016-3 (RCMT 2016-3) | LMM Originated conventional | November 2016 | Active | 162.1 |
ReadyCap Commercial Mortgage Trust 2018-4 (RCMT 2018-4) | LMM Originated conventional | March 2018 | Active | 165.0 |
Ready Capital Mortgage Trust 2019-5 (RCMT 2019-5) | LMM Originated conventional | January 2019 | Active | 355.8 |
Ready Capital Mortgage Trust 2019-6 (RCMT 2019-6) | LMM Originated conventional | November 2019 | Active | 430.7 |
Ready Capital Mortgage Trust 2022-7 (RCMT 2022-7) | LMM Originated conventional | April 2022 | Active | 276.8 |
Waterfall Victoria Mortgage Trust 2011-2 (SBC2) | LMM Acquired loans | March 2011 | Collapsed | 97.6 |
Sutherland Commercial Mortgage Trust 2018 (SBC6) | LMM Acquired loans | August 2017 | Active | 154.9 |
Sutherland Commercial Mortgage Trust 2019 (SBC8) | LMM Acquired loans | June 2019 | Active | 306.5 |
Sutherland Commercial Mortgage Trust 2020 (SBC9) | LMM Acquired loans | June 2020 | Collapsed | 203.6 |
Sutherland Commercial Mortgage Trust 2021 (SBC10) | LMM Acquired loans | May 2021 | Active | 232.6 |
Collateralized Loan Obligations (CLOs) | ||||
Ready Capital Mortgage Financing 2017– FL1 | LMM Originated bridge | August 2017 | Collapsed | 198.8 |
Ready Capital Mortgage Financing 2018 – FL2 | LMM Originated bridge | June 2018 | Collapsed | 217.1 |
Ready Capital Mortgage Financing 2019 – FL3 | LMM Originated bridge | April 2019 | Collapsed | 320.2 |
Ready Capital Mortgage Financing 2020 – FL4 | LMM Originated bridge | June 2020 | Collapsed | 405.3 |
Ready Capital Mortgage Financing 2021 – FL5 | LMM Originated bridge | March 2021 | Collapsed | 628.9 |
Ready Capital Mortgage Financing 2021 – FL6 | LMM Originated bridge | August 2021 | Collapsed | 652.5 |
Ready Capital Mortgage Financing 2021 – FL7 | LMM Originated bridge | November 2021 | Active | 927.2 |
Ready Capital Mortgage Financing 2022 – FL8 | LMM Originated bridge | March 2022 | Collapsed | 1,135.0 |
Ready Capital Mortgage Financing 2022 – FL9 | LMM Originated bridge | June 2022 | Active | 754.2 |
Ready Capital Mortgage Financing 2022 – FL10 | LMM Originated bridge | October 2022 | Active | 860.1 |
Ready Capital Mortgage Financing 2023 – FL11 | LMM Originated bridge | February 2023 | Active | 586.0 |
Ready Capital Mortgage Financing 2023 – FL12 | LMM Originated bridge | June 2023 | Active | 648.6 |
Trusts (Non-firm sponsored) | ||||
Freddie Mac Small Balance Mortgage Trust 2016-SB11 | Originated agency multi-family | January 2016 | Active | 110.0 |
Freddie Mac Small Balance Mortgage Trust 2016-SB18 | Originated agency multi-family | July 2016 | Active | 118.0 |
Freddie Mac Small Balance Mortgage Trust 2017-SB33 | Originated agency multi-family | June 2017 | Active | 197.9 |
Freddie Mac Small Balance Mortgage Trust 2018-SB45 | Originated agency multi-family | January 2018 | Active | 362.0 |
Freddie Mac Small Balance Mortgage Trust 2018-SB52 | Originated agency multi-family | September 2018 | Active | 505.0 |
Freddie Mac Small Balance Mortgage Trust 2018-SB56 | Originated agency multi-family | December 2018 | Active | 507.3 |
Key Commercial Mortgage Trust 2020-S3(1) | LMM Originated conventional | September 2020 | Active | 263.2 |
12-month pretax net interest income sensitivity profiles | |||||||||||||||
Instantaneous change in rates | |||||||||||||||
(in thousands) | 25 basis point increase | 50 basis point increase | 75 basis point increase | 100 basis point increase | 25 basis point decrease | 50 basis point decrease | 75 basis point decrease | 100 basis point decrease | |||||||
Assets: | |||||||||||||||
Loans | $12,465 | $25,176 | $37,919 | $50,674 | $(12,352) | $(24,105) | $(35,433) | $(46,580) | |||||||
Interest rate swap hedges | 1,058 | 2,116 | 3,174 | 4,232 | (1,058) | (2,116) | (3,174) | (4,232) | |||||||
Total | $13,523 | $27,292 | $41,093 | $54,906 | $(13,410) | $(26,221) | $(38,607) | $(50,812) | |||||||
Liabilities: | |||||||||||||||
Secured borrowings | (6,235) | (12,470) | (18,704) | (24,939) | 6,235 | 12,470 | 18,704 | 24,939 | |||||||
Securitized debt obligations | (5,010) | (10,020) | (15,030) | (20,039) | 5,010 | 10,020 | 15,030 | 20,039 | |||||||
Senior secured notes and corporate debt | (379) | (758) | (1,136) | (1,515) | 379 | 758 | 1,136 | 1,515 | |||||||
Total | $(11,624) | $(23,248) | $(34,870) | $(46,493) | $11,624 | $23,248 | $34,870 | $46,493 | |||||||
Total Net Impact to Net Interest Income (Expense) | $1,899 | $4,044 | $6,223 | $8,413 | $(1,786) | $(2,973) | $(3,737) | $(4,319) |
March 31, 2025 | |||||||
(in thousands) | Counterparty Rating | Amount of Risk | Weighted Average Months to Maturity for Agreement | Percentage of Stockholders’ Equity | |||
JPMorgan Chase Bank, N.A. | AA-/Aa2 | $608,301 | 16 | 29.8% |
Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs | Maximum Shares (or Approximate Dollar Value) That May Yet Be Purchased Under the Program | |||||
January | 207 | $6.62 | — | $150,000,000 | ||||
February | 286,280 | 6.62 | — | 150,000,000 | ||||
March | 3,447,557 | 5.02 | 3,443,935 | 132,698,476 | ||||
Total | 3,734,044 | (1) | $5.14 | (2) | 3,443,935 | $132,698,476 |
Exhibit number | Exhibit description | |
2.1 | * | |
3.1 | * | |
3.2 | * | |
3.3 | * | |
3.4 | * | |
3.5 | * | |
3.6 | * | |
3.7 | * | |
3.8 | * | |
3.9 | * | |
3.10 | * | |
4.1 | * | |
4.2 | * | |
4.3 | * | |
4.4 | * | |
4.5 | * | |
4.6 | * | |
4.7 | * |
4.8 | * | |
4.9 | * | |
4.10 | * | |
4.11 | * | |
4.12 | * | |
4.13 | * | |
4.14 | * | |
4.15 | * | |
4.16 | * | |
10.1 | * | |
31.1 | ||
31.2 | ||
32.1 | ** | |
32.2 | ** |
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
101.SCH | Inline XBRL Taxonomy Extension Scheme Document | |
101.CAL | Inline XBRL Taxonomy Calculation Linkbase Document | |
101.DEF | Inline XBRL Extension Definition Linkbase Document | |
101.LAB | Inline XBRL Taxonomy Extension Linkbase Document | |
101.PRE | Inline XBRL Taxonomy Presentation Linkbase Document | |
104 | Cover Page Interactive Data File (embedded with the Inline XBRL document) |
* | Previously filed. |
** | This exhibit is being furnished rather than filed, and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K. |
Date: May 9, 2025 | By: | /s/ Thomas E. Capasse |
Thomas E. Capasse | ||
Chairman of the Board, Chief Executive Officer and Chief Investment Officer | ||
(Principal Executive Officer) | ||
Date: May 9, 2025 | By: | /s/ Andrew Ahlborn |
Andrew Ahlborn | ||
Chief Financial Officer | ||
(Principal Accounting and Financial Officer) |